DRNA
Dicerna Pharmaceuticals, Inc.
DRNA
DRNA
Delisted
DRNA was delisted on the 27th of December, 2021.
50 hedge funds and large institutions have $32.4M invested in Dicerna Pharmaceuticals, Inc. in 2016 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 16 increasing their positions, 13 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
50
Holders Change
+2
Holders Change %
+4.17%
% of All Funds
1.25%
Holding in Top 10
1
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-66.67%
% of All Funds
0.03%
New
11
Increased
16
Reduced
13
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
DCM
51
DAFNA Capital Management
Los Angeles,
California
| – | -$701K | -119,300 | Closed |
|
|
OAM
52
Oxford Asset Management
Oxford,
United Kingdom
| – | -$347K | -59,006 | Closed |
|
|
ACA
53
Avoro Capital Advisors
New York
| – | -$271K | -46,082 | Closed |
|
54
JPMorgan Chase & Co
New York
| – | -$78K | -13,278 | Closed |
|
55
ProShare Advisors
Bethesda,
Maryland
| – | -$77K | -13,089 | Closed |
|
|
CS
56
Credit Suisse
Zurich,
Switzerland
| – | -$60K | -10,245 | Closed |
|
|
TFCP
57
Twin Focus Capital Partners
Boston,
Massachusetts
| – | -$59K | -10,000 | Closed |
|
58
Walleye Trading
New York
| – | -$12K | -2,100 | Closed |
|